Abstract
Nowadays, allogeneic hematopoietic cell transplantation is the cure for several patients with benign and malignant hematologic diseases. Many complications can occur after bone marrow transplant and the Graft-versus-host disease (GVHD) is one of the most important due to mortality and impact on quality of life. Approximately 50% of patients have some manifestation of chronic GVHD, althoug…